conferenceseries LLC Ltd Scientific Program...G Aguirre, Hakken Enterprise S.A. de C.V., Mexico...
Transcript of conferenceseries LLC Ltd Scientific Program...G Aguirre, Hakken Enterprise S.A. de C.V., Mexico...
conferenceseries LLC Ltd
Conference Series LLC Ltd | 47 Churchfield Road, London, UK, W3 6AY Toll Free: +44-800-014-8923
conferenceseries LLC Ltd Scientific Program
September 17-18, 2018 | San Diego, USA
28th International Conference on
Joint Event
&
&
Cancer Research and Anticancer TherapiesInternational Conference on
Oncogenesis & Oncologic Emergency Medicine3rd International Conference on
Tumor & Cancer Immunology and Immunotherapy
Page 2
Day 1 September 17, 2018
Conference Hall: HILLCREST-II08:30-09:00 Registrations
09:00-09:15 Opening Ceremony
Keynote Forum09:15-09:45 Title: Sugar and cancer: A 7-year, controlled study Colleen Huber, Naturopathic Cancer Society, USA
09:45-10:15 Title: Expression of programmed cell death 1 ligands in histiocytic and dendritic cell
neoplasms Jie Xu, MD Anderson Cancer Center, USA
10:15-10:45 Title: FOX(M1) and Cancer Andrei L Gartel, University of Illinois at Chicago, USA
Panel Discussion & Group PhotoNetworking & Refreshment Break 10:45-11:00 @ Foyer
11:00-11:30 Title: Novel small-molecule Stat5 Inhibitor for further optimization and clinical
development for cancer therapy Marja T Nevalainen, Medical College of Wisconsin, USA
11:30-12:00 Title: Self-similarity and T-patterns from cell city to the only big-brain mass-societies
formed in a recent eye-blink: Proteomics as bio-sociology Magnus S Magnusson, University of Iceland, Iceland
Panel Discussion 12:00-12:10Sessions: Natural Methods for Cancer Treatment | Targeted Cancer Therapies| Hematology-Oncology| Oncogenomics |Cancer Pharmacology| Oncology | Cancer Biology | Cancer Screening| Immune Check-point Inhibitors |Cancer Research & Cancer VaccinesSession Chair: Marja T Nevalainen, Medical College of Wisconsin, USA
Session Introduction
12:10-12:35Title: Effects of newer anti-cancer agents on the kidneyKetki Tendulkar, University of Nebraska Medical Center, USA
12:35-13:00Title: Affinity of the anti-cancer preparation NSC631570 (Ukrain) to the cancer cellsWassil Nowicky, Ukrainian Anti-Cancer Institute, Austria
Panel Discussion Lunch Break 13:00-14:00 @ Kensington Veranda
14:00-14:25Title: Oral Mucocitis: A very common oral side effect of radio-chemotherapyNarjiss Akerzoul, Mohammed V University Of Rabat, Morocco
14:25-14:50Title: Herpes simplex virus oncolytic vectors (oHSV) armed with the NKG2D ligand ULBP3 enhances treatment of gliomas Joseph C Glorioso, University of Pittsburgh School of Medicine, USA
14:50-15:15Title: Indian treatment for Leukemia and other cancersJames Vaidyan, Ayurveda Vaidyasala, Center for Cancer Treatment, India
15:15-15:40Title: Exosomes of human melanoma cells induce cancer development in human dermal cells through rab27a and c-met Ozge Sezin Somuncu, Bahcesehir University, Turkey
Networking & Refreshment Break 15:40-15:55 @ Cortez Foyer
Page 3
15:55-16:20Title: GanplexTM and Kimera-TestTM : Biotechnological screening tools designed identify human cancer-related virus and SNPs in non-invasive samplesG Aguirre, Hakken Enterprise S.A. de C.V., Mexico
16:20-16:45Title: Kaposi sarcoma and human herpus virus type 8: A rare case and review of the literatureNarjiss Akerzoul, Mohammed V University Of Rabat, Morocco
16:45-17:10Title: TriMix and antigen mRNA based vaccinationKarine Breckpot, Vrije Universiteit Brussel, Brussel
Panel Discussion 17:10-17:30
Day 2 September18, 2018
Conference Hall: HILLCREST-IIKeynote Forum
09:00-09:30 Title: Circulating Cell-free DNA (ccf-DNA) in cancer patients: From DNA integrity index to liquid biopsy Azza Mahmoud Kamel, NCI, Cairo University, Egypt
09:30-10:00 Title: Etiopathology of Wilms’ Tumor in India - Genetic Heterogeneity and Increasing “Risk
Factor” involving Novel Gene Mutations of MTHFR gene polymorphism Ajit Kumar Saxena, All India Institute of Medical Sciences, India
10:00-10:30 Title: Anti-Cancer preparation NSC 631570 (UKRAIN): Modulation of the Immune system Wassil Nowicky, Ukrainian Anti-Cancer Institute, Austria
10:30-10:50 Title: The tsunami of immune-oncology in pancreatic adenocarcinoma: success or failure Voravud Narin, King Chulalongkorn Memorial Hospital, Thailand
Networking & Refreshment Break 10:50-11:05 @ Cortez FoyerPanel Discussion 11:05-11:20
Sessions: Pediatric Oncology | Oncology | Chemotherapy | Skin Cancer | Cancer Therapy | Cancer Biology | Cancer Screening | Cancer Prognosis & Diagnosis | Cancer Immunology & Immunotherapy | Immuno-Oncology Studies | Tumor ImmunologySession Chair: Ashok Srivastava, ClinFomatrix, USA
Session Introduction
11:20-11:40Title: Burkitt lymphoma: a successful chemo-sensible malignant process Narjiss Akerzoul, Mohammed V University Of Rabat, Morocco
11:40-12:00Title: Effect of nutritional counseling on quality of life of breast cancer patients: An intervention studyDoaa A Saleh, Cairo University, Egypt
Young Researchers Forum
12:00-12:20Title: Molecular mechanisms involved in acquired chemotherapeutic drug resistance to 5-FU in colorectal cancerNidhi Abraham, VIC, La Trobe University, Australia
12:20-12:40Title: A practical guide to the treatment of melanoma during pregnancySarah J Vitug, University of Queensland, Australia
12:40-13:00Title: Design, synthesis and evaluation of Indolylbenzenesulfonamides as potent HDAC inhibitorsSamir Mehndiratta, Taipei Medical University, Taiwan
Lunch Break 13:00-13:50 @ Kensington Veranda
13:50-14:10Title: Anti-metastatic activity of Albizia lebbeck stem bark extract against breast cancer cell linesHuzaifa Umar, Cyprus International University, Turkey
Panel DiscussionWork Shop on "Targeting FOX M1 in Cancer" by Andrei L Gartel @ 14:10- 15:10
Page 4
Panel Discussion & Group Photo 15:10-15:20Networking & Refreshment Break 15:20-15:40 @ Cortez Foyer
Video Presentations 15:40-16:15
V 01Title: Cytotoxic, apoptotic and tumor regressive efficacy of PLGA encapsulated diosgenin nanoparticles in cancer cell linesSujata Maiti Choudhury, Vidyasagar University, India
V 02Title: Indole-3-carbinol-mediated biogenic gold nanoparticles provoke cell death by inducing oxidative stress and apoptosis in T cell leukemia and lymphomaAnanya Pradhan, Vidyasagar University, India
V 03Title: Prognostic factors for surgical outcome and survival in women treated for borderline ovarian tumorsMohamed Zakaria Abdel-Rahman Sayer Dayer, Menoufia University, Egypt
Poster Presentations 16:15-17:15 @ Cortez FoyerPoster Judge: Ajit Kumar Saxena, All India Institute of Medical Sciences, India
P 01Title: Advance preoperative assessment of cancer patients leads to lower percentage of same day cancellations, increasing positive perioperative patient experienceKaty E French, MD Anderson Cancer Center, USA
P 02Title: GanplexTM and Kimera-TestTM: Biotechnological screening tools designed identify human cancer-related virus and SNPs in non-invasive samples Meda-Monzón E, Hakken Enterprise S.A. de C.V., México
P 03Title: Indole-3-ethylsulfamoylphenylacrylamides with Potent Anti-proliferative and Anti- angiogenic Activities Samir Mehndiratta, Taipei Medical University, Taiwan
P 04Title: Flagellin mutant of Salmonella Typhimurium VNP20009 producing recombinant mouse PD-1 preserves the growth kinetics and mobility of the parental strain Edyta Zyla, Jagiellonian University, Poland
Panel Discussion 17:15-17:30 Thanks Giving & Closing Ceremony